Attaining United States and European guideline LDL-C levels with simvastatin in patients with coronary heart disease (the GOALLS study).

作者信息

Mikhailidis D P, Wierzbicki A S

机构信息

Department of Molecular Pathology & Clinical Biochemistry, Royal Free and University College Medical School, Royal Free Campus, London NW3 2QG, UK.

出版信息

Curr Med Res Opin. 2000;16(3):205-7.

PMID:11191011

Abstract

摘要

相似文献

Attaining United States and European guideline LDL-C levels with simvastatin in patients with coronary heart disease (the GOALLS study).

Curr Med Res Opin. 2000;16(3):205-7.

Attaining United States and European guideline LDL-cholesterol levels with simvastatin in patients with coronary heart disease (the GOALLS study).

Curr Med Res Opin. 2000;16(3):208-19.

LDL-C goal attainment with the addition of ezetimibe to ongoing simvastatin treatment in coronary heart disease patients with hypercholesterolemia.

Curr Med Res Opin. 2005 Apr;21(4):571-8. doi: 10.1185/030079905X382004.

Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease.

Int J Cardiol. 2005 Jul 10;102(2):327-32. doi: 10.1016/j.ijcard.2005.01.022.

Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.

Curr Med Res Opin. 2006 Mar;22(3):511-28. doi: 10.1185/030079906X89856.

Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.

Am J Geriatr Pharmacother. 2007 Sep;5(3):185-94. doi: 10.1016/j.amjopharm.2007.10.002.

[New combination therapy. Up to 60% lower LDL cholesterol level].

MMW Fortschr Med. 2004 May 6;146(19):63.

Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia.

Nutr Metab Cardiovasc Dis. 2000 Oct;10(5):253-62.

Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study.

Curr Med Res Opin. 2005 Sep;21(9):1389-99. doi: 10.1185/030079905X59139.

Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.

Diabetes Obes Metab. 2005 Jul;7(4):430-8. doi: 10.1111/j.1463-1326.2004.00450.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验